These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 20940383)
21. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961 [TBL] [Abstract][Full Text] [Related]
22. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Middleton LS; Nuzzo PA; Lofwall MR; Moody DE; Walsh SL Addiction; 2011 Aug; 106(8):1460-73. PubMed ID: 21395892 [TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. Sigmon SC; Dunn KE; Saulsgiver K; Patrick ME; Badger GJ; Heil SH; Brooklyn JR; Higgins ST JAMA Psychiatry; 2013 Dec; 70(12):1347-54. PubMed ID: 24153411 [TBL] [Abstract][Full Text] [Related]
24. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder. Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432 [TBL] [Abstract][Full Text] [Related]
25. Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence. Soyka M Expert Opin Drug Deliv; 2012 Nov; 9(11):1409-17. PubMed ID: 23013384 [TBL] [Abstract][Full Text] [Related]
26. Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence. Saleh MI Pharmacopsychiatry; 2014 Nov; 47(7):251-8. PubMed ID: 25321188 [TBL] [Abstract][Full Text] [Related]
27. The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial. Ahmadi J; Jahromi MS; Ehsaei Z Trials; 2018 Aug; 19(1):462. PubMed ID: 30157924 [TBL] [Abstract][Full Text] [Related]
28. A trial of integrated buprenorphine/naloxone and HIV clinical care. Sullivan LE; Barry D; Moore BA; Chawarski MC; Tetrault JM; Pantalon MV; O'Connor PG; Schottenfeld RS; Fiellin DA Clin Infect Dis; 2006 Dec; 43 Suppl 4():S184-90. PubMed ID: 17109305 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting. Amato P Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244 [TBL] [Abstract][Full Text] [Related]
30. A controlled trial of buprenorphine treatment for opioid dependence. Johnson RE; Jaffe JH; Fudala PJ JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593 [TBL] [Abstract][Full Text] [Related]
32. Novel Buccal Film Formulation of Buprenorphine-Naloxone for the Maintenance Treatment of Opioid Dependence: A 12-Week Conversion Study. Sullivan JG; Webster L Clin Ther; 2015 May; 37(5):1064-75. PubMed ID: 25823919 [TBL] [Abstract][Full Text] [Related]
36. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Weiss RD; Potter JS; Fiellin DA; Byrne M; Connery HS; Dickinson W; Gardin J; Griffin ML; Gourevitch MN; Haller DL; Hasson AL; Huang Z; Jacobs P; Kosinski AS; Lindblad R; McCance-Katz EF; Provost SE; Selzer J; Somoza EC; Sonne SC; Ling W Arch Gen Psychiatry; 2011 Dec; 68(12):1238-46. PubMed ID: 22065255 [TBL] [Abstract][Full Text] [Related]
37. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J; Sittl R Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693 [TBL] [Abstract][Full Text] [Related]
38. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. Fiellin DA; Pantalon MV; Chawarski MC; Moore BA; Sullivan LE; O'Connor PG; Schottenfeld RS N Engl J Med; 2006 Jul; 355(4):365-74. PubMed ID: 16870915 [TBL] [Abstract][Full Text] [Related]
39. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Strain EC; Stoller K; Walsh SL; Bigelow GE Psychopharmacology (Berl); 2000 Mar; 148(4):374-83. PubMed ID: 10928310 [TBL] [Abstract][Full Text] [Related]
40. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]